美国Barrett食管相关食管腺癌的患病、内镜后及新发特征:大型回顾性队列研究
该研究基于美国2004–2019年商业和Medicare Advantage健康计划数据,纳入50,817例新发Barrett食管(BE)患者,其中366例发展为食管腺癌(EAC)。67.2%为患病EAC(指数内镜后30天内诊断),13.7%为内镜后EAC(PEEC,30–365天),19.1%为新发EAC(≥365天)。男性、吞咽困难、体重减轻及Charlson-Deyo评分与患病EAC正相关;多数有症状者症状在EAC诊断前3个月内首次记录。
要点
- 约三分之二BE相关EAC在BE诊断时即被发现(患病EAC)。
- 内镜后EAC(PEEC)占BE相关EAC的14%。
- 男性、吞咽困难、体重减轻和高共病评分与患病EAC相关。
核心结论
- 在BE患者中,三分之二的EAC在BE诊断时即被诊断,PEEC占14%。
研究设计与样本
- 回顾性队列研究,使用美国2004–2019年大型商业和Medicare Advantage健康计划数据,纳入50,817例新发BE患者。
主要发现
- 366例发展为EAC,其中67.2%为患病EAC,13.7%为PEEC,19.1%为新发EAC。
- 与无患病EAC的BE患者相比,患病EAC正相关因素包括男性、吞咽困难、体重减轻和Charlson-Deyo共病评分。
- 在患病EAC患者中,多数吞咽困难或体重减轻者的症状首次记录于EAC诊断前3个月内。
- 有和无患病EAC者的医疗利用 rates 相似。
临床怎么用
- BE诊断时需警惕同步存在的EAC,尤其对于男性、有吞咽困难、体重减轻或高共病评分的患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Efforts to assess and improve the effectiveness of Barrett's esophagus (BE) screening and surveillance are ongoing in the United States. Currently, there are limited population-based data in the United States to guide these efforts. METHODS: We performed a retrospective cohort study using data from large commercial and Medicare Advantage health plans in the United States from 2004 - 2019. We identified individuals with BE and analyzed the proportion who developed EAC. EACs were classified as prevalent EAC (diagnosed within 30 days of index endoscopy), post-endoscopy esophageal adenocarcinoma (PEEC, diagnosed 30 - 365 days after index endoscopy), and incident EAC (diagnosed 365 days or more after index endoscopy). Using this cohort, we performed a nested case-control study to identify factors associated with prevalent EAC at BE diagnosis and study healthcare utilization prior to BE diagnosis. RESULTS: We identified 50,817 individuals with incident BE. Of the 366 who developed EAC, 67.2%, 13.7%, and 19.1% were diagnosed with prevalent EAC, PEEC, and incident EAC respectively. Factors positively associated with prevalent EAC versus BE without prevalent EAC included male sex, dysphagia, weight loss, and Charlson-Deyo comorbidity score. In those with prevalent EAC, most patients with dysphagia or weight loss had their symptoms first recorded within three months of EAC diagnosis. Healthcare utilization rates were similar between those with and without prevalent EAC. CONCLUSIONS: Two-thirds of EACs among individuals with BE are diagnosed at the time of BE diagnosis. Additionally, PEEC accounts for 14% of these EACs. These results may guide future research studies that investigate novel BE diagnostic strategies that reduce the morbidity and mortality of EAC.
引用
- Vajravelu RK, Kolb JM, Thanawala SU, et al. Characterization of Prevalent, Post-Endoscopy, and Incident Esophageal Cancer in the United States: A Large Retrospective Cohort Study. Clin Gastroenterol Hepatol. 2021. PMID: 33549872. doi:10.1016/j.cgh.2021.02.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。